A systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancer

Cyclo-oxygenase type 2 is dysregulated in breast ductal carcinoma in situ and correlates with poor outcome

(2010) Javier de la Torre et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Aspirin Intake and Survival After Breast Cancer

(2010) Michelle D. Holmes et al.   JOURNAL OF CLINICAL ONCOLOGY

Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis

(2010) K. Kerlikowske et al.   JNCI-Journal of the National Cancer Institute

Microinvasive Carcinoma of the Breast

(2009) Simonetta Bianchi et al.   PATHOLOGY & ONCOLOGY RESEARCH

Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung

(2009) R. E. Harris   INFLAMMOPHARMACOLOGY

COX-2 and PPARγ expression are potential markers of recurrence risk in mammary duct carcinoma in-situ

(2008) Swati Kulkarni et al.   BMC CANCER

Cyclooxygenase-2 Expression during Immortalization and Breast Cancer Progression

(2008) X. Zhao et al.   CANCER RESEARCH

Estrogen-Dependent Prognostic Significance of Cyclooxygenase-2 Expression in Early-Stage Invasive Breast Cancers Treated With Breast-Conserving Surgery and Radiation

(2008) Bruce G. Haffty et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Breast Cancer and Use of Nonsteroidal Anti-inflammatory Drugs: A Meta-analysis

(2008) B. Takkouche et al.   JNCI-Journal of the National Cancer Institute